These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35061505)

  • 1. SLAMF3 and SLAMF4 are immune checkpoints that constrain macrophage phagocytosis of hematopoietic tumors.
    Li D; Xiong W; Wang Y; Feng J; He Y; Du J; Wang J; Yang M; Zeng H; Yang YG; Wu N; Chen S; Dong Z
    Sci Immunol; 2022 Jan; 7(67):eabj5501. PubMed ID: 35061505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
    Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
    Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 4. CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis.
    Morrissey MA; Kern N; Vale RD
    Immunity; 2020 Aug; 53(2):290-302.e6. PubMed ID: 32768386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor cell-to-macrophage communication by blocking Vtn-C1qbp interaction inhibits tumor progression via enhancing macrophage phagocytosis.
    Zhang C; Liu Y; Jiang J; Chen C; Duan Z; Su H; Wang S; Tian B; Shi Y; Xiang R; Luo Y
    Theranostics; 2024; 14(7):2757-2776. PubMed ID: 38773982
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
    Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
    mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
    Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
    J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance.
    Chen J; Cao X; Li B; Zhao Z; Chen S; Lai SWT; Muend SA; Nossa GK; Wang L; Guo W; Ye J; Lee PP; Feng M
    Front Immunol; 2020; 11():621757. PubMed ID: 33603751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1.
    Guo H; Cranert SA; Lu Y; Zhong MC; Zhang S; Chen J; Li R; Mahl SE; Wu N; Davidson D; Waggoner SN; Veillette A
    J Exp Med; 2016 Sep; 213(10):2187-207. PubMed ID: 27573813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.
    Wang H; Sun Y; Zhou X; Chen C; Jiao L; Li W; Gou S; Li Y; Du J; Chen G; Zhai W; Wu Y; Qi Y; Gao Y
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education.
    Chen S; Yang M; Du J; Li D; Li Z; Cai C; Ma Y; Zhang L; Tian Z; Dong Z
    Immunity; 2016 Aug; 45(2):292-304. PubMed ID: 27521267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity.
    Wang X; Wang Y; Hu J; Xu H
    Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell recognition of hematopoietic cells by SLAM-SAP families.
    Chen S; Dong Z
    Cell Mol Immunol; 2019 May; 16(5):452-459. PubMed ID: 30911116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47.
    Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG
    Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression.
    Lin Y; Zhao JL; Zheng QJ; Jiang X; Tian J; Liang SQ; Guo HW; Qin HY; Liang YM; Han H
    Front Immunol; 2018; 9():1744. PubMed ID: 30105024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells.
    Ko YJ; Lee JW; Kim H; Cho E; Yang Y; Kim IS; Kim SH; Kwon IC
    J Control Release; 2020 Jul; 323():376-386. PubMed ID: 32335154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy.
    Li Z; Li Y; Gao J; Fu Y; Hua P; Jing Y; Cai M; Wang H; Tong T
    Life Sci; 2021 May; 273():119150. PubMed ID: 33662426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(I:C) enhances the efficacy of phagocytosis checkpoint blockade immunotherapy by inducing IL-6 production.
    Zhong C; Wang L; Hu S; Huang C; Xia Z; Liao J; Yi W; Chen J
    J Leukoc Biol; 2021 Dec; 110(6):1197-1208. PubMed ID: 33988261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.